The endothelium plays a key role in providing appropriate haemostatic balance. Endothelial progenitor cells (EPCs) are involved in the maintenance of endothelial haemostasis and in the process of forming new vessels. Cardiovascular disease (CVD) is associated with reduced numbers and dysfunction of endothelial cells (ECs) and EPCs. The beneficial effects of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-Co-A) reductase inhibitors (atorvastatin), helps to restore of EPCs and improvement in vascular function. This review underlines the pleiotropic effects of atorvastatin on ECs and EPCs.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Download PDF 
Post
